Utilico Insights - Jacqueline Broers assesses why Vietnam could be the darling of Asia for investors. Watch the full video here.

Less Ads, More Data, More Tools Register for FREE
Stefan Bernstein explains how the EU/Greenland critical raw materials partnership benefits GreenRoc
Stefan Bernstein explains how the EU/Greenland critical raw materials partnership benefits GreenRocView Video
Utilico Insights - Jacqueline Broers assesses why Vietnam could be the darling of Asia for investors
Utilico Insights - Jacqueline Broers assesses why Vietnam could be the darling of Asia for investorsView Video

Latest Share Chat

Medicinal Cannabis Firm Cellular Goods Raises GBP13 Million In IPO

Tue, 23rd Feb 2021 13:51

(Alliance News) - Cellular Goods PLC on Tuesday said it raised GBP13 million in its initial public offering amid strong demand from both institutional and private investors.

The London-based cannabinoids products firm said it will have a market capitalisation of GBP25 million at the IPO price and will be the first pure-play biosynthetic cannabinoids consumer products company to list on the main market of the London Stock Exchange.

Cellular Goods said earlier this month it hoped to raise GBP8 million in its IPO.

The company said 260 million shares, 52% of its total, will be issued at an offer price of 5 pence a share. A total of 192 million shares have been conditionally placed with institutional investors and 68 million have been allocated to retail investors through PrimaryBid.

"We want to involve as many private investors as possible so that they can both be part of and benefit from our growth as we become the trusted brand in consumer cannabinoids. Technology now means that listening at scale is not just a possibility but a requirement for successful consumer brands. We firmly believe that the future of the cannabinoid industry will be driven by biosynthetic production and our significantly oversubscribed IPO is a sign of investor confidence in this future," said Chief Executive Alexis Abraham.

Cellular Goods said it will have a total of 504.8 million shares in issue upon admission to the LSE, which is expected to be on Friday. Its ticker will be CBX.

Cash from the IPO will be used to finalise the development of, and launch, of its initial cannabinoid-based product range for cosmetics and sports recovery, the company said.

Tennyson Securities and Novum Securities are acting as Cellular Goods' joint bookrunners and brokers.

By Zoe Wickens; zoewickens@alliancenews.com

Copyright 2021 Alliance News Limited. All Rights Reserved.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.